Analyst consensus rating
Biodesix Analyst Rating: Strong Buy
Direct answer
Biodesix's consensus rating is Strong Buy.
6 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $39.00.
Forecast evidence checked October 17, 2026.
Get free Biodesix email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $23.66
- Average price target
- $39.00
- High price target
- $41.00
- Low price target
- $35.00
- Low target gap
- +47.9%
- Target upside
- +64.8%
- High target gap
- +73.3%
- Target range width
- 25.4%
- Consensus rating
- Strong Buy
- Analysts
- 6
- Evidence date
- October 17, 2026
- Valid through
- October 24, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Biodesix?
Biodesix has a verified Strong Buy consensus. The same dataset has an average price target of $39.00.
How far are Biodesix's low and high targets from the recorded price?
The low target implies +47.9%, while the high target implies +73.3%.
How many analysts are included in Biodesix's consensus?
The verified consensus includes 6 analysts.
How is Biodesix's target upside or downside calculated?
The average target of $39.00 is divided by the recorded price of $23.66, then one is subtracted to produce +64.8%. This does not guarantee a future return.
When was Biodesix's analyst forecast verified?
The data was verified on 2026-10-17. The dataset is valid through 2026-10-24.